Aventiv Research is currently conducting clinical studies in Columbus for type 1 and type 2 diabetes. You may be eligible to participate in a diabetes clinical trial and contribute to the development and approval of a new or improved drug or treatment. As a participant, there is no cost to you at any point during the study and you may be compensated for time and participation. Fill out the form below to enroll in a diabetes clinical trial being conducted at our Columbus, Ohio facility.
Aventiv Research is currently enrolling for multiple diabetes studies. The ideal candidates for our diabetes clinical trials will be over the age of 18 and have had type 1 or type 2 diabetes for at least 5 years. Typical A1C should not span beyond a range greater than 11%.
We’re looking primarily for candidates who are generally healthy who have not experienced complications from diabetes or cardiovascular events.
Diabetes affects millions of Americans, and without proper management can lead to debilitating complications. Diabetes results from the body’s inability to produce or use insulin, causing elevated blood glucose levels.
People with diabetes can sometimes manage the symptoms through diet and exercise, but in more severe cases medication may be necessary to maintain steady glucose levels.
Millions of dollars are spent every year to research the causes and discover new treatments for the disease.
Diabetes clinical trials are the last phase of the research and development process for new medications. If you suffer from diabetes you could qualify to participate in one. Pharmaceutical companies are continually working to develop new medications to control diabetes. If you qualify for a diabetes clinical trial, you may have access to life-changing medication that is not yet available to most patients.
Most research facilities will provide all the necessary exams, lab work and related medications at no cost to the patient. Some will also pay for time and travel necessary for participation.
Diabetes clinical trials might focus on controlling blood sugar, some may be testing drugs that can simulate insulin, and others might address lifestyle changes to control diabetes symptoms.